Soluble receptor for advanced glycation end products in physiological and pathological pregnancy

Clinical Biochemistry

Volumn 43, Issue 4-5, 2010, Pages 442-446

  Germanová, Anna ^a   Koucký, Michal ^a   Hájek, Zdeněk ^a   Pařízek, Antonín ^a   Zima, Tomáš ^a   Kalousová, Marta ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Preeclampsia; Pregnancy; Preterm labor; RAGE, receptor for advanced glycation end products; soluble receptor for advanced glycation end products, sRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; CREATININE; URIC ACID;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LEUKOCYTE COUNT; PHYSIOLOGICAL PROCESS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SECOND TRIMESTER PREGNANCY; SOLUBILITY; THIRD TRIMESTER PREGNANCY; URIC ACID BLOOD LEVEL;

ADULT; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTERS; RECEPTORS, IMMUNOLOGIC; SOLUBILITY;

EID: 77049125246     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.11.002     Document Type: Article

References (35)

1. Schmidt A.M., Hori O., Chen J.X., et al. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule 1 (VCAM - 1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96 (1995) 1395-1403
2. Schmidt A.M., Yanc S.D., Yana S.F., and Stern D.M. The biology of the receptor for advanced glycation end products and its ligand. BBA - Mol. Cell. Res. 1498 (2000) 99-111
3. Falcone C., Emanuele E., D'Angelo A., et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in non diabetic men. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 1032-1037
4. Hofmann M.A., Drury S., Hudson B.I., et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 3 (2002) 125-135
5. Kalousová M., Hoďková M., Kazderová M., et al. Soluble receptor for advanced glycation end products in patients with decreased renal function. Am. J. Kidney Dis. 47 (2006) 406-411
6. Hudson B.I., Harja E., Moser B., and Schmidt A.M. Soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease. The next C-reactive protein. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 879-882
7. Hudson B.I., and Schmidt A.M. RAGE: a novel target for drug intervention in diabetic vascular disease. Pharm. Res. 21 (2004) 1079-1086
8. Pullerits R., Bokarewa M., Dahlberg R., and Tarkowski A. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res. Ther. 7 (2005) 817-824
9. Park L., Roman K.G., Kee K.J., et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4 (1998) 1025-1031
10. Wear-Maggitti K., Lee J., Conejero A., Schmidt A.M., Grant R., and Breitbart A. Use of topical sRAGE in diabetic wounds increases neovascularization and granulation tissue formation. Ann. Plast. Surg. 52 (2004) 519-521
11. Zhang H., Tasaka S., Shiraishi Y., et al. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am. J. Respir. Care Med. 178 (2008) 256-262
12. Chekir C., Nakatsuka M., Noguchi S., et al. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nutritive stress. Placenta 27 (2006) 225-233
13. Cooke C.L., Brockelsby J.C., Baker P.N., and Davidge S.T. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens. Pregnancy 22 (2003) 173-184
14. Buhimschi I.A., Zhao G., Pettker C.M., et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am. J. Obstet. Gynecol. 196 181 (2007) e1-e13
15. Romero R., Espinoza J., Hassan S., et al. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J. Perinat. Med. 36 (2008) 388-398
16. Hájek Z. Germanová A, Koucký M et al. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J. Perinat. Med. 36 (2008) 399-404
17. Pertynska-Marczewska M., Glowacka E., Sobczak M., Cypryk K., and Wilczynski J. Glycation end products, soluble receptor for advanced glycation end products and cytokines in diabetic and non-diabetic pregnancies. Am. J. Reprod. Immunol. 61 (2009) 175-182
18. Fasshauer M., Seeger J., Waldeyer T., et al. Endogenous soluble receptor for advanced glycation end products is increased in preeclampsia. J. Hypertens. 26 (2008) 1824-1828
19. Fialová L., Malbohan I., Kalousová M., et al. Oxidative stress and inflammation in pregnancy. Scand. J. Clin. Lab. Invest. 66 (2006) 121-127
20. Arikan S., Konukoglu D., Arican C., Akcay T., and Davas T. Lipid peroxidation and antioxidant status in maternal and cord blood. Gynecol. Obstet. Invest. 51 (2001) 145-149
21. Belo L., Santos-Silva A., Rocha S., et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 123 (2005) 46-51
22. AAgaard-Tillery K.M., Silver R., and Dalton J. Immunology of normal pregnancy. Semin. Fetal. Neonatal. Med. 11 (2006) 279-295
23. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int. Rev. Immun. 21 (2002) 471-495
24. Keelan J.A., Marwin K.W., Sato T.A., Coleman M., McCowan L.M., and Mitchell M.D. Cytokine abundance in placental tissues evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am. J. Obstet. Gynecol. 181 (1999) 1530-1536
25. Osman I., Young A., Ledingham M.A., et al. Leukocyte density and pro-inflammatory expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol. Human Reprod. 9 (2003) 41-45
26. Young A., Thomson A.J., Ledingham M., Jordan F., Greer I.A., and Norma J.E. Immunolocalization of proinflammatory cytokines in mymetrium, cervix, and fetal membranes during human parturition at term. Biol. Reprod. 66 (2002) 445-449
27. Bopp C., Hofer S., Weitz J., et al. sRAGE is elevated in septic patients and associated with patients outcome. J. Surg. Res. 147 (2008) 79-83
28. Wittkowski H., Sturrock A., and van Zoelen M.A. Neutrophil - derived S100A12 in acute lung injury and respiratory distress syndrome. Crit. Care Med. 35 (2007) 1369-1375
29. Romero R., Espinoza J., Goncalves L.F., Kusanovic J.P., Friel L., and Nien N.K. Inflammation in preterm and term labour and delivery. Semin. Fetal. Neonatal. Med. 11 (2006) 317-326
30. Lee S.E., Romero R., Park I.S., Seong H.S., Park C.W., and Yoon B.H. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J. Matern. Fetal. Neonatal Med. 21 (2008) 89-94
31. Jang Y., Kim J.Y., Kang S.M., et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56 (2007) 199-295
32. Geroldi D., Falcone C., Emanuele E., et al. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J. Hypertens. 23 (2005) 1725-1729
33. Xia Y., Wen H., Bobst S., Day M.C., and Kellems R.E. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J. Soc. Gynecol. Investig. 10 (2003) 82-93
34. Forbes J.M., Thorpe S.R., Thallas-Bonke V., et al. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J. Am. Soc. Nephrol. 16 (2005) 2363-2372
35. Bainbridge S.A., and Roberts J.M. Uric acid as a pathogenic factor in preeclampsia. Placenta 29 (2008) 67-72